Illumina Aims at Roche for Tests Seen Worth $25 Billion

Illumina Aims at Roche for Tests Seen Worth $25 Billion

Illumina Inc. via Bloomberg

The headquarters of Illumina Inc. stands in San Diego, California, U.S. Illumina’s Sept. 19 announcement that it was buying BlueGnome Ltd. to expand its capabilities followed by just two days a report by BGI-Shenzhen, a Chinese operator of genome-sequencing centers, that it would buy Complete Genomics Inc.